D. Akkaya Et Al. , "In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease," DRUG DEVELOPMENT RESEARCH , vol.85, no.17968444, pp.1-10, 2024
Akkaya, D. Et Al. 2024. In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease. DRUG DEVELOPMENT RESEARCH , vol.85, no.17968444 , 1-10.
Akkaya, D., Seyhan, G., Sari, S., & Barut, B., (2024). In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease. DRUG DEVELOPMENT RESEARCH , vol.85, no.17968444, 1-10.
Akkaya, DİDEM Et Al. "In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease," DRUG DEVELOPMENT RESEARCH , vol.85, no.17968444, 1-10, 2024
Akkaya, DİDEM Et Al. "In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease." DRUG DEVELOPMENT RESEARCH , vol.85, no.17968444, pp.1-10, 2024
Akkaya, D. Et Al. (2024) . "In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease." DRUG DEVELOPMENT RESEARCH , vol.85, no.17968444, pp.1-10.
@article{article, author={DİDEM AKKAYA Et Al. }, title={In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease}, journal={DRUG DEVELOPMENT RESEARCH}, year=2024, pages={1-10} }